Elaine Tanhehco to Dogs
This is a "connection" page, showing publications Elaine Tanhehco has written about Dogs.
Connection Strength
0.137
-
Long-term pharmacological activation of PPARgamma does not prevent left ventricular remodeling in dogs with advanced heart failure. Cardiovasc Drugs Ther. 2007 Feb; 21(1):29-36.
Score: 0.017
-
Long-term therapy with the acorn cardiac support device normalizes gene expression of growth factors and gelatinases in dogs with heart failure. J Heart Lung Transplant. 2005 Oct; 24(10):1619-25.
Score: 0.016
-
Long-term effects of non-excitatory cardiac contractility modulation electric signals on the progression of heart failure in dogs. Eur J Heart Fail. 2004 Mar 01; 6(2):145-50.
Score: 0.014
-
Reversal of chronic molecular and cellular abnormalities due to heart failure by passive mechanical ventricular containment. Circ Res. 2003 Nov 28; 93(11):1095-101.
Score: 0.014
-
Hypoxia, angiotensin-II, and norepinephrine mediated apoptosis is stimulus specific in canine failed cardiomyocytes: a role for p38 MAPK, Fas-L and cyclin D1. Eur J Heart Fail. 2003 Mar; 5(2):121-9.
Score: 0.013
-
Cardiac contractility modulation with nonexcitatory electric signals improves left ventricular function in dogs with chronic heart failure. J Card Fail. 2003 Feb; 9(1):69-75.
Score: 0.013
-
Effects of the AT1-receptor antagonist eprosartan on the progression of left ventricular dysfunction in dogs with heart failure. Br J Pharmacol. 2003 Jan; 138(2):301-9.
Score: 0.013
-
Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failure. Circulation. 2002 Dec 03; 106(23):2967-72.
Score: 0.013
-
Effects of long-term monotherapy with metoprolol CR/XL on the progression of left ventricular dysfunction and remodeling in dogs with chronic heart failure. Cardiovasc Drugs Ther. 2002 Sep; 16(5):443-9.
Score: 0.013
-
Effects of chronic neutral endopeptidase inhibition on the progression of left ventricular dysfunction and remodeling in dogs with moderate heart failure. Cardiovasc Drugs Ther. 2002 May; 16(3):209-14.
Score: 0.012